7.9000
22-November-24 07:05:01
15 minutes delayed
Stocks
+0.1800
+2.33%
Today's range
7.9000 - 7.9000
ISIN
BE0974358906
Source
Cboe
Nyxoah and Vanderbilt University enter exclusive licensing agreement regarding next generation neurostimulation technologies to treat Obstructive Sleep Apnea (OSA)
01 Feb 2021 23:56:05 By Nasdaq GlobeNewswire
Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)
26 Jan 2021 00:02:09 By Nasdaq GlobeNewswire
First US patient implanted in the DREAM pivotal IDE study, with the Genio® system for the treatment of Obstructive Sleep Apnea (OSA)
05 Jan 2021 00:39:42 By Nasdaq GlobeNewswire